Homecare Encounters: An Organizational Response to Innovative Care for Patients Undergoing Hematopoietic Stem Cell Transplantation During COVID-19.
Adult
Aged
Aged, 80 and over
COVID-19
/ epidemiology
Female
Hematopoietic Stem Cell Transplantation
/ nursing
Home Care Services
/ standards
Humans
Male
Middle Aged
Neoplasms
/ nursing
North Carolina
Oncology Nursing
/ standards
Pandemics
Practice Guidelines as Topic
SARS-CoV-2
Therapies, Investigational
/ standards
Transplantation, Homologous
/ nursing
COVID-19
hematopoietic stem cell transplantation
home care
home encounters
Journal
Clinical journal of oncology nursing
ISSN: 1538-067X
Titre abrégé: Clin J Oncol Nurs
Pays: United States
ID NLM: 9705336
Informations de publication
Date de publication:
01 08 2021
01 08 2021
Historique:
entrez:
16
7
2021
pubmed:
17
7
2021
medline:
23
7
2021
Statut:
ppublish
Résumé
Healthcare delivery has been significantly changed because of the COVID-19 pandemic. Patients undergoing hematopoietic stem cell transplantation (HSCT) are vulnerable to infections because of their immunocompromised status. The risk of nosocomial infection may be reduced by providing care to patients at home. This article describes one cancer center's approach for delivering safe patient care through homecare encounters, the benefits of home care for HSCT, and future directions. Patients received detailed information on home encounters. Advanced practice providers visited patients daily and then returned to the clinic to formulate a plan of care with the interprofessional care team. Transplantation RNs visited patients on the same day to provide the prescribed care. Based on evaluations from 32 patients and 12 providers, the results indicated that home care was safe, feasible, and beneficial for patient care post-HSCT during the COVID-19 pandemic.
Sections du résumé
BACKGROUND
Healthcare delivery has been significantly changed because of the COVID-19 pandemic. Patients undergoing hematopoietic stem cell transplantation (HSCT) are vulnerable to infections because of their immunocompromised status. The risk of nosocomial infection may be reduced by providing care to patients at home.
OBJECTIVES
This article describes one cancer center's approach for delivering safe patient care through homecare encounters, the benefits of home care for HSCT, and future directions.
METHODS
Patients received detailed information on home encounters. Advanced practice providers visited patients daily and then returned to the clinic to formulate a plan of care with the interprofessional care team. Transplantation RNs visited patients on the same day to provide the prescribed care.
FINDINGS
Based on evaluations from 32 patients and 12 providers, the results indicated that home care was safe, feasible, and beneficial for patient care post-HSCT during the COVID-19 pandemic.
Identifiants
pubmed: 34269347
doi: 10.1188/21.CJON.457-464
doi:
Types de publication
Journal Article
Langues
eng